Statistically significant improvements observed across clinical endpoints; final cohort results expected in Q2 2025 ...

Second Cohort Results Highlight Efficacy Across All Key Measures and Reinforce Safety of Twice-Daily Oral RinsePhase 2a Study Now Fully Enrolled ...

Moss and lichen may grow on solid, undisturbed surfaces, such as trees on your property. And though they aren't necessarily ...

Whether anything ever lived on Mars is unknown. And the present environment, with harsh temperatures, intense radiation, and ...

Lichenification occurs when repeated scratching or rubbing causes skin to thicken and become leathery. Certain skincare and treatment options may help reduce the reaction.

“The completion of enrollment in our Phase 2a trial marks an important step in advancing a non-steroidal, locally delivered treatment for oral lichen planus ... that could cause actual results ...

Lipella Pharmaceuticals has concluded subject enrollment in its multicentre Phase IIa trial of liposomal tacrolimus oral rinse LP-310, which is aimed at treating oral lichen planus (OLP).

OLP is a chronic, T-cell-mediated autoimmune disorder affecting the oral mucosa, often causing painful erosions, inflammation and ulcerative lesions. The condition impacts an estimated 6 million ...

PITTSBURGH, April 08, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology ...

Credit: MacroEcon/Shutterstock. Lipella Pharmaceuticals has concluded subject enrollment in its multicentre Phase IIa trial of liposomal tacrolimus oral rinse LP-310, which is aimed at treating oral ...